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Dear Sir,
Transient cortical blindness (CB) is a
rare but dramatic dye-induced complication
associated with coronary angiography (only
11 cases are known). It is characterized by
complete loss of visual perception with pres-
ervation of ocular motility, papillary re-
sponses and normal fundoscopic examina-
tion. CB is selective functional impairment
of the occipital visual cortex. Symptoms of
dye-induced CB result from extravasation of
the contrast medium into the posterior circu-
lation of the brain.
We report on a 52-year-old hypertensive
patient with end-stage renal failure and a
LIMA bypass graft developing blindness im-
mediately following diagnostic coronary an-
giography. 400 ml of the contrast agent io-
pamidol were applied. Immediately follow-
ing angiography, the patient complained of
visual impairment which progressed to com-
plete blindness within 30 min. Neurologic
examinations including fundoscopy and pu-
pillary responses were normal. A CT of the
brain performed 3 h after angiography re-
vealed extensive contrast extravasation into
the posterior circulation (fig. 1A, B). The fol-
lowing day, the patient’s vision improved
gradually. A second CT scan 30 h after angi-
ography showed only residual enhancement
(fig. 1E, F). Three days after catheterization,
the patient’s vision returned to normal.
Currently used non-ionic contrast media
have an osmolality which is about twice that
of plasma. The intravascular injection of hy-
perosmolar contrast agents causes a tran-
sient increase in blood osmolality, leading to
a temporary breakdown of the blood-brain
barrier in some patients. Subsequent injec-
tions may result in extravasation of the dye
into the subarachnoid space and brain tissue
resulting in neurological deficits due to di-
rect neurotoxic effects of the contrast me-
dium. The exact mechanism of the neurotox-
icity is still unclear. Factors that may con-
tribute to the disruption of the blood-brain
barrier are decreased clearance of the sub-
stance in patients with impaired renal func-
tion and pre-existing endothelial dysfunc-
tion in patients with cardiovascular risk fac-
tors.
CB after coronary angiography was re-
ported following both high-osmolality ionic
[1, 2] and modern low-osmolality non-ionic
contrast agents [3–7]. The incidence and du-
ration of blindness seem to be unrelated to
the dose of contrast medium applied. The
majority of the patients had previously been
exposed to dye without developing any neu-
rological symptoms. Four patients with a
history of CB were re-exposed to contrast
medium within a few months [4, 5]. They
were pretreated with corticosteroids, and a
relatively small amount of contrast agent
was given (80–180 ml). In 3 cases [5], re-
exposure did not lead to recurrence of CB. In
contrast, 1 patient [4] developed CB again.
Thus, patients with CB following previous
contrast medium exposure may be at in-
creased risk of developing CB at re-exposure.
In the future, if re-exposure to a contrast
medium in patients with previous CB is
inevitable, pre-treatment with corticoste-
roids should be performed and the smallest
possible amount of contrast medium should
be given.
Five of the 12 cases observed to date (ta-
ble 1) had a LIMA bypass graft. As the LIMA
graft and the left vertebral artery arise in
close proximity to the subclavian artery, it is
possible that during repeated attempts at
selective cannulation of the LIMA graft, a
considerable amount of contrast medium
passed into the left vertebral artery. If dye
applied at the beginning of the procedure has
already led to disruption of the blood-brain
barrier, selective injection of the vertebral
artery may result in extravasation of a large
amount of contrast medium into the posteri-
or circulation. Thus, in patients with a LIMA
bypass graft, we suggest to perform injection
of the LIMA graft at the beginning of the
procedure and to avoid selective vertebral
artery injection if possible.
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Fig. 1. A, B CT scan 4 h after catheteriza-
tion: contrast extravasation into the suba-
rachnoid space and enhancement of the cere-
bellum, the occipital cortex, the posterior
part of the temporal gyri and the left thala-
mus. C, D MRI scan 5 h after catheteriza-
tion: in the diffusion weighted images, slight
signal increase in the cerebellar hemispheres.
Normal signal in the T2-weighted images.
E, F CT scan 30 h after catheterization: still
enhancement of both occipital and dorsal
temporal lobes. Contrast medium remnant
in the local sulci.
In future cases of visual impairment fol-
lowing heart catheterization, a CT of the
brain without additional contrast medium
should be performed immediately. If no
signs of acute thromboembolism are present
and subarachnoidal extravasation of the
contrast medium could be documented, the
diagnosis of dye-induced CB can be made.
Thus the prognosis of CB is excellent, the
most important step is to reassure the pa-
tient that symptoms will resolve completely
within a few days. No therapy has been prov-
en to be effective, therefore no additional
steps should be taken.
In future studies on dye-induced CB, all
pre-existing cardiovascular risk factors and
the actual renal function of the patient
should be assessed in order to better identify
possible risk groups and to develop prophy-
lactic and therapeutic strategies. The excel-
lent prognosis of CB justifies re-exposure un-
der the above-mentioned precautions.
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Table 1. Summary of all known cases with CB following coronary angiography
Sex Age Contrast
medium
Osmolality
mosm/kg
Volume
injected
cm3
Duration
of CB
Previous
exposure
LIMA
bypass
graft
Impaired
renal
function
Arterial
hyper-
tension
1 W 52 Diatrizoate 2,100 NI 18 h no no NI yes
2 W 57 Ioxaglate 577 200 48 h yes yes no yes
3 M 55 Diatrizoate 2,100 228 24 h yes no NI yes
4 M 61 Diatrizoate 2,100 210 36 h yes yes NI yes
5 M 44 Diatrizoate 2,100 112 12 h no no NI yes
6 M 59 Ioversol 790 220 12 h yes no NI NI
7 M 45 Ioversol 790 167 24 h yes no NI NI
8 M 68 Ioversol 790 262 15 min no no NI NI
9 M 62 Iopamidol 774 270 72 h yes yes NI yes
10 M 55 Iomeprol 610 280 120 h yes yes NI no
11 M 53 Ioversol 790 100 12 h no no NI NI 
12 M 52 Iopamidol 774 400 72 h yes yes yes yes
NI = Not indicated.
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